Erratum: Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors (Blood (2014) 123:9 1309-1318))

H. M. Kantarjian, Jorge E Cortes, D. W. Kim

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors (Blood (2014) 123:9 1309-1318))'. Together they form a unique fingerprint.